Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 in Relation to Hyperglycemia and Diabetes Mellitus
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Mohamd A. Alblihed, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 107

Showing 1-25 of 107 citing articles:

Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Hany Akeel Al-Hussaniy, et al.
International Immunopharmacology (2022) Vol. 104, pp. 108516-108516
Open Access | Times Cited: 147
The potential role of neopterin in Covid-19: a new perspective
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Khalid J. Alzahrani, et al.
Molecular and Cellular Biochemistry (2021) Vol. 476, Iss. 11, pp. 4161-4166
Open Access | Times Cited: 68
COVID-19 and corticosteroids: a narrative review
Gaber El‐Saber Batiha, Ali I. Al‐Gareeb, ‏Hebatallah M. Saad, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 4, pp. 1189-1205
Open Access | Times Cited: 59
Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals
Hayder M. Al‐kuraishy, Gaber El‐Saber Batiha, Hani Faidah, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 2017-2026
Open Access | Times Cited: 57
Niclosamide for Covid-19: bridging the gap
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Khalid J. Alzahrani, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 12, pp. 8195-8202
Open Access | Times Cited: 56
Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Gomaa Mostafa‐Hedeab, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 56
The Prospective Effect of Allopurinol on the Oxidative Stress Index and Endothelial Dysfunction in Covid-19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Marwa S. Al‐Niemi, et al.
Inflammation (2022) Vol. 45, Iss. 4, pp. 1651-1667
Open Access | Times Cited: 52
Post-COVID syndrome, inflammation, and diabetes
Ali A. Rizvi, Amita Kathuria, Wael Al Mahmeed, et al.
Journal of Diabetes and its Complications (2022) Vol. 36, Iss. 11, pp. 108336-108336
Open Access | Times Cited: 52
Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2022) Vol. 31, Iss. 1, pp. 1-7
Open Access | Times Cited: 37
Gut microbiota in patients with COVID-19 and type 2 diabetes: A culture-based method
Pavlo Petakh, Nazarii Kobyliak, Oleksandr Kamyshnyi
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 26
Depression and type 2 diabetes: A causal relationship and mechanistic pathway
Wael Y. Khawagi, Hayder M. Al‐kuraishy, Nawar R. Hussein, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 8, pp. 3031-3044
Open Access | Times Cited: 10
Impact of Sitagliptin on Non-diabetic Covid-19 Patients
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Current Molecular Pharmacology (2021) Vol. 15, Iss. 4, pp. 683-692
Closed Access | Times Cited: 41
Hyperglycemia and Loss of Redox Homeostasis in COVID-19 Patients
Marí­a Elena Soto, Verónica Guarner‐Lans, Eulises Díaz‐Díaz, et al.
Cells (2022) Vol. 11, Iss. 6, pp. 932-932
Open Access | Times Cited: 31
Ginkgo biloba in the management of the COVID‐19 severity
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ajeet Kaushik, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 10
Open Access | Times Cited: 27
Protective effect of ursodeoxycholic acid on COVID-19 in patients with chronic liver disease
Yanyan Li, Na Zhu, Xinyu Cui, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 19
Correlation between COVID-19 vaccination and diabetes mellitus: A systematic review
Yanfei He, Jing Ouyang, Xiao Hu, et al.
World Journal of Diabetes (2023) Vol. 14, Iss. 6, pp. 892-918
Open Access | Times Cited: 18
COVID-19 pneumonia and the subsequent risk of getting active pulmonary tuberculosis: a population-based dynamic cohort study using national insurance claims databases
Ponlagrit Kumwichar, Virasakdi Chongsuvivatwong
EClinicalMedicine (2023) Vol. 56, pp. 101825-101825
Open Access | Times Cited: 16
Effects of neprilysin and neprilysin inhibitors on glucose homeostasis: Controversial points and a promising arena
Faisal Alanazi, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Diabetes (2023) Vol. 15, Iss. 5, pp. 397-408
Open Access | Times Cited: 15
Increased angiotensin converting enzyme (ACE2) level is associated with the cardiovascular risk in diabetes
Gurramkonda Naveena, Meera Shivasekar, VM Vinodhini, et al.
Indian Journal of Physiology and Pharmacology (2025), pp. 1-6
Closed Access
Quantitative serum proteomic analysis for biomarker discovery in post-COVID-19 postural orthostatic tachycardia syndrome (PC-POTS) patients
Taekyung Ryu, Brittany Adler, Seeun Judy Jeong, et al.
Autonomic Neuroscience (2025) Vol. 258, pp. 103247-103247
Open Access
Association of Mediterranean Diet with Cardiovascular Risk Factors and with Metabolic Syndrome in Subjects with Long COVID: BioICOPER Study
Nuria Suárez-Moreno, Leticia Gómez‐Sánchez, Alicia Navarro-Cáceres, et al.
Nutrients (2025) Vol. 17, Iss. 4, pp. 656-656
Open Access
Decrypting the Possible Mechanistic Role of Fenofibrate in Alzheimer's Disease and Type 2 Diabetes: The Truth and Mystery
Mansour Alsaleem, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 5
Open Access
Factors Behind the Higher COVID-19 Risk in Diabetes: A Critical Review
Amany Magdy Beshbishy, Victor B. Oti, Diaa E. Hussein, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 34
Vinpocetine is the Forthcoming Adjuvant Agent in the Management of COVID-19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Muyiwa Samuel Fageyinbo, et al.
Future Science OA (2022) Vol. 8, Iss. 5
Open Access | Times Cited: 26
Characteristics of lymphocyte subsets and cytokine profiles of patients with COVID-19
Pengfei Pan, Xinxin Du, Qilong Zhou, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top